HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer

Maureen P Martin1, Ingrid B Borecki, Zhengyan Zhang

  • 1Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC-Frederick, Inc. NCI-Frederick, Frederick, MD 21702, USA.

Immunogenetics
|September 22, 2010
PubMed